We are a group of people, affected directly or indirectly by Parkinson’s:
- We have to deal with the effects of the disease on a daily basis.
- The life of carers is heavily influenced by our varying needs.
That’s why we are interested in all possibilities to stop or slow down the progression of the illness and – moreover – never give up the hope, that research will come up with a cure for Parkinson’s.
This event, being hosted by PUK and the 4 Scottish RIGs for World Parkinson's Day, promises to be a fascinating event. We will be hearing from researchers who are at the cutting edge of PD research globally, based here in Scotland. As well as consultants and People with Parkinson's and their families.
The Activate study, conducted by the pharmaceutical company Bial R&D Investments, is a recently-started clinical trial to test a new medication for the treatment of Parkinson’s disease in patients with a GBA1 gene mutation.